Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19540640 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
Conditions: Major Coronary Event;   Cerebrovascular Accident;   Coronary Artery Bypass Graft;   Angina, Unstable;   Revascularization
Intervention: Drug: Atorvastatin

Study has passed its completion date and status has not been verified in more than two years.